Circulation device company requests CAD (coronary artery disease) coverage
This article was originally published in Clinica
Executive Summary
The Health Care Financing Administration (HCFA) is considering whether to expand the scope of Medicare's coverage of external counterpulsation (ECP), a noninvasive therapy which is used to treat coronary artery disease (CAD). Medicare, the federal health plan for the elderly and disabled, currently covers ECP only to treat certain patients with stable angina pectoris.